AAAAAA
Results:
1-7
|
Results: 7
Authors:
Checler, F
da Costa, CA
Ancolio, K
Chevallier, N
Lopez-Perez, E
Marambaud, P
Citation: F. Checler et al., Role of the proteasome in Alzheimer's disease, BBA-MOL BAS, 1502(1), 2000, pp. 133-138
Authors:
Ancolio, K
da Costa, CA
Ueda, K
Checler, F
Citation: K. Ancolio et al., alpha-Synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells, NEUROSCI L, 285(2), 2000, pp. 79-82
Authors:
da Costa, CA
Ancolio, K
Checler, F
Citation: Ca. Da Costa et al., Wild-type but not Parkinson's disease-related Ala-53 -> Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli, J BIOL CHEM, 275(31), 2000, pp. 24065-24069
Authors:
da Costa, CA
Ancolio, K
Checler, F
Citation: Ca. Da Costa et al., C-terminal maturation fragments of presenilin 1 and 2 control secretion ofAPP alpha and A beta by human cells and are degraded by proteasome, MOL MED, 5(3), 1999, pp. 160-168
Authors:
Ancolio, K
Dumanchin, C
Barelli, H
Warter, JM
Brice, A
Campion, D
Frebourg, T
Checler, F
Citation: K. Ancolio et al., Unusual phenotypic alteration of beta amyloid precursor protein (beta APP)maturation by a new Val-715 -> Met beta APP-770 mutation responsible for probable early-onset Alzheimer's disease, P NAS US, 96(7), 1999, pp. 4119-4124
Authors:
Marambaud, P
Ancolio, K
da Costa, CA
Checler, F
Citation: P. Marambaud et al., Effect of protein kinase A inhibitors on the production of A beta 40 and Abeta 42 by human cells expressing normal and Alzheimer's disease-linked mutated beta APP and presenilin 1, BR J PHARM, 126(5), 1999, pp. 1186-1190
Authors:
Marambaud, P
Chevallier, N
Ancolio, K
Checler, F
Citation: P. Marambaud et al., Post-transcriptional contribution of a cAMP-dependent pathway to the formation of alpha- and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wildtype and Swedish mutated beta APP, MOL MED, 4(11), 1998, pp. 715-723
Risultati:
1-7
|